1. Is Hester Biosciences Ltd a good quality company?
Past 10 year's financial track record analysis by Moneyworks4me indicates that Hester Biosciences Ltd is a good quality company.
2. Is Hester Biosciences Ltd undervalued or overvalued?
The key valuation ratios of Hester Biosciences Ltd's currently when compared to its past seem to suggest it is in the Fair zone.
3. Is Hester Biosciences Ltd a good buy now?
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Hester Biosciences Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
Value Creation ⓘ
Value Creation Index Colour Code Guide ⓘ
|ROCE % ⓘ||14.2%||14.4%||12.9%||16.8%||18.1%||18.3%||22.5%||14.5%||18.5%||12.5%||-|
|Value Creation Index ⓘ||0.0||0.0||-0.1||0.2||0.3||0.3||0.6||0.0||0.3||-0.1||-|
Growth Parameters ⓘ
Growth Parameters Colour Code Guide ⓘ
|YoY Gr. Rt. %||-||6.1%||30.4%||12.1%||22.2%||9.3%||27%||-1%||23.1%||5.2%||-|
|Adj EPS ⓘ||11.4||11.9||14.2||22.8||29.3||35.8||50.9||35.7||51.6||45.4||38|
|YoY Gr. Rt. %||-||4.3%||19.3%||60.9%||28.7%||22%||42.4%||-29.8%||44.3%||-11.9%||-|
|BVPS (₹) ⓘ||79.8||89.3||99||117.9||143.5||171.7||210.9||238.7||279.3||315.5||321.4|
|Adj Net Profit ⓘ||9.7||10.1||12||19.4||24.9||30.4||43.3||30.4||43.9||38.6||32|
|Cash Flow from Ops. ⓘ||13.4||11.4||20.4||18.6||27.6||32.3||36.2||25.8||41.1||15.9||-|
|Debt/CF from Ops. ⓘ||1.8||3.1||1.9||2.1||1.4||1.3||1.1||1.9||0.4||7.7||-|
CAGR Colour Code Guide ⓘ
|9 Years||5 Years||3 Years||1 Years|
|Adj EPS ⓘ||16.6%||9.2%||-3.8%||-11.9%|
Key Financial Parameters ⓘ
Performance Ratio Colour Code Guide ⓘ
|Return on Equity % ⓘ||15.1||14||15||21||22.4||22.7||26.6||15.9||19.9||15.3||11.9|
|Op. Profit Mgn % ⓘ||34.4||36.7||28.5||33.4||33.4||36.8||39.7||31.1||34.7||26.7||24.4|
|Net Profit Mgn % ⓘ||14.9||14.6||13.4||19.2||20.2||22.6||25.3||18||21||17.6||15.3|
|Debt to Equity ⓘ||0.4||0.5||0.5||0.4||0.3||0.3||0.2||0.2||0.1||0.5||-|
|Working Cap Days ⓘ||267||290||231||229||217||220||208||261||245||281||0|
|Cash Conv. Cycle ⓘ||200||202||163||160||140||140||134||164||145||166||0|
No data to display
Return on Equity has declined versus last 3 years average to 11.90%
Sales growth has been subdued in last 3 years 8.61%
Net Profit has been subdued in last 3 years -3.75%
Sales growth is not so good in last 4 quarters at -6.58%
|TTM EPS (₹)||38||36.2|
|TTM Sales (₹ Cr.)||211||226|
|BVPS (₹.) ⓘ||321.4||308|
|Reserves (₹ Cr.) ⓘ||265||253|
|From the Market|
|52 Week Low / High (₹)||1963.90 / 2851.75|
|All Time Low / High (₹)||0.25 / 3180.00|
|Market Cap (₹ Cr.)||1,673|
|Equity (₹ Cr.)||8.5|
|Face Value (₹)||10|
|Industry PE ⓘ||37.9|
Hester Biosciences was incorporated on April 29, 1987 as a Private Limited Company by the name of Hester Pharmaceuticals Limited. It was subsequently converted into a Public Limited Company on November 1, 1993. The company is engaged in the manufacturing of poultry vaccines. The company has been promoted by Rajiv D. Gandhi his brother Sanjiv D. Gandhi and Dr. Bhupendra V. Gandhi. The company changed its name to the present in 2008.
The company is a 100% biotech company producing animal biologicals. Located near the city of Ahmedabad, in the state of Gujarat, in Western India, Hester has a state-of-the-art facility to produce live and killed (Inactivated) veterinary vaccines.
Production procedures for poultry vaccines based on in-house advanced capabilities are being followed in the areas of virus propagation in specific pathogen-free embryos, tissue culture, batch fermentation of bacteria, lyophilisation and emulsion preparation.
Hester on December 22, 2008 launched a poultry vaccine against Coryza disease in chicken, containing 3 serotypes â€“ A, B & C.
Hester is the first company in India to manufacture the Coryza vaccine with 3 strains as against other companies manufacturing the vaccine with only 2 serotypes - A & C. Coryza disease is of economical importance to poultry farmers as it causes a drop in egg production in laying birds.
Hester currently manufactures 39 types of poultry vaccines against various poultry diseases.
Product range of the company includes: